Recent articles
Filters
Article types
Publication dates
Issues
Expanding the results
Sections
Access

126 - 150 of 280 Items

Original paper2023, jul 21

Hyperandrogenism-related metabolic changes in drug-naïve transmen compared to cisgender women: a case-controlled study

Pınar Erel, Onur Elbasan, Neşe Yorguner, Eren İmre, Özlem Üstay

Vol 74, No 4 (2023)

Original paper

Pubmed: 37577993
Endokrynol Pol 2023;74(4):398-403.
Clinical vignette2023, jul 18

Difficulties in achieving euthyroid status in a patient with differentiated thyroid cancer after sleeve gastrectomy

Adam Daniel Durma, Marek Saracyn, Anna Celina Durma, Grzegorz Kamiński

Vol 74, No 4 (2023)

Clinical vignette

Pubmed: 37578001
Endokrynol Pol 2023;74(4):439-440.
Clinical vignette2023, jul 18

Lethargic patient with hepatocirrhosis — more than meets the eye

Mateusz Maligłówka, Aleksandra Sojka, Anna Bartecka, Łukasz Bułdak, Bogusław Okopien

Vol 74, No 4 (2023)

Clinical vignette

Pubmed: 37578000
Endokrynol Pol 2023;74(4):443-444.
Original paper2023, jul 18

Functional status as a predictor of the incidence of falls in 10-year follow-up: results from the RAC-OST-POL study

Wojciech Pluskiewicz, Piotr Adamczyk, Bogna Drozdzowska

Vol 74, No 4 (2023)

Original paper

Pubmed: 37577992
Endokrynol Pol 2023;74(4):404-407.
Original paper2023, jul 18

Evaluation of pulmonary side effects in prolactinoma patients treated with cabergoline

Ozlem Soyluk, Zuleyha Bingol, Sema Ciftci, Neslihan Kurtulmus, Seher Tanrikulu, Sema Yarman

Vol 74, No 4 (2023)

Original paper

Pubmed: 37577991
Endokrynol Pol 2023;74(4):380-384.
Original paper2023, jul 11

Differences in clinical characteristics, treatment, and outcomes of sporadic and MEN-1-related insulinomas

Marta Opalińska, Aleksandra Gilis-Januszewska, Karolina Morawiec-Sławek, Anna Kurzyńska, Anna Sowa-Staszczak, Anna Bogusławska, Ewelina Rzepka, Alicja Hubalewska-Dydejczyk

Vol 74, No 4 (2023)

Original paper

Pubmed: 37431872
Endokrynol Pol 2023;74(4):363-371.
Review paper2023, jun 30

The influence of SGLT2 inhibitors on oxidative stress in heart failure and chronic kidney disease in patients with type 2 diabetes

Diana Nabrdalik-Leśniak, Katarzyna Nabrdalik, Krzysztof Irlik, Oliwia Janota, Hanna Kwiendacz, Paulina Szromek-Białek, Mirosław Maziarz, Tomasz Stompór, Janusz Gumprecht, Gregory Y. H. Lip

Vol 74, No 4 (2023)

Review paper

Pubmed: 37431873
Endokrynol Pol 2023;74(4):349-362.
Clinical vignette2023, jun 26

Diagnostic and therapeutic difficulties in a patient with corticotropic pituitary macroadenoma

Grzegorz Erbert, Elżbieta Łomna-Bogdanov, Marek Bolanowski

Vol 74, No 4 (2023)

Clinical vignette

Pubmed: 37431874
Endokrynol Pol 2023;74(4):437-438.
Original paper2023, jun 21

Osteoporosis treatment with denosumab in routine clinical practice in Poland

Ewa Marcinowska-Suchowierska, Tomasz Blicharski, Ewa Wielosz, Maria Rell-Bakalarska, Krzysztof Duma, Katarzyna Paradowska-Kowal, Ewa Sewerynek

Vol 74, No 3 (2023)

Original paper

Pubmed: 37695033
Endokrynol Pol 2023;74(3):243-253.
Original paper2023, jun 21

Bioinformatics analysis of CUL2/4A/9 and its function in head and neck squamous cell carcinoma

Bingqing Xu, Ruohuang Wang, Jisheng Zhang, Lin Wang, Xin Cui, Fangyu Chai, Xiaoyun Du, Yan Jiang

Vol 74, No 3 (2023)

Original paper

Pubmed: 37695034
Endokrynol Pol 2023;74(3):315-330.
Clinical vignette2023, jun 21

Progression of a corticotroph tumour during durable medical therapy with osilodrostat in a patient with persistent Cushing’s disease

Bartłomiej Borawski, Agnieszka Wojciechowska-Luźniak, Grzegorz Zieliński, Przemysław Witek

Vol 74, No 3 (2023)

Clinical vignette

Pubmed: 37695035
Endokrynol Pol 2023;74(3):346-347.
Original paper2023, jun 20

Association between TSH suppression therapy and type 2 deiodinase gene polymorphism in differentiated thyroid carcinoma

Xiaoke Zheng, Lichang Zhong, Tianjiao Zhou, Feng Zhao, Bin Chen

Vol 74, No 4 (2023)

Original paper

Pubmed: 37431871
Endokrynol Pol 2023;74(4):408-413.
Review paper2023, jun 12

Impact of alirocumab/evolocumab on lipoprotein (a) concentrations in patients with familial hypercholesterolaemia: a systematic review and meta-analysis of randomized controlled trials

Haibing Dai, Yonglin Zhu, Zuyi Chen, Renqing Yan, Jinsong Liu, Ziyun He, Lin Zhang, Feng Zhang, Shengkai Yan

Vol 74, No 3 (2023)

Review paper

Pubmed: 37335067
Endokrynol Pol 2023;74(3):234-242.
Original paper2023, jun 12

Demographics, practice patterns, job satisfaction, and career plans of endocrinologists in Poland

Wojciech S. Zgliczyński, Adam Skowron

Vol 74, No 3 (2023)

Original paper

Pubmed: 37335066
Endokrynol Pol 2023;74(3):331-339.
Original paper2023, jun 12

The effects of 3-year growth hormone treatment and body composition in Polish patients with Silver-Russell syndrome

Anna Świąder-Leśniak, Dorota Jurkiewicz, Honorata Kołodziejczyk, Agata Kozłowska, Alicja Korpysz, Mieczysław Szalecki, Krystyna Chrzanowska

Vol 74, No 3 (2023)

Original paper

Pubmed: 37335065
Endokrynol Pol 2023;74(3):285-293.
Clinical vignette2023, jun 12

COVID-19 infection in a patient with Cushing’s disease on osilodrostat treatment

Anna Bogusławska, Mari Minasyan, Alicja Hubalewska-Dydejczyk, Aleksandra Gilis-Januszewska

Vol 74, No 3 (2023)

Clinical vignette

Pubmed: 37335068
Endokrynol Pol 2023;74(3):342-343.
Original paper2023, may 29
Original paper2023, may 15

Irisin attenuates pyroptosis in high glucose-induced pancreatic beta cells via the miR-133a-3p/FOXO1 axis

Anjun Tan, Tianrong Li, Jingjing Yang, Jinwen Yu, Hewen Chen

Vol 74, No 3 (2023)

Original paper

Pubmed: 37335063
Endokrynol Pol 2023;74(3):277-284.
Review paper2023, may 9

The influence of various endocrine disruptors on the reproductive system

Agata Czarnywojtek, Magdalena Borowska, Kamil Dyrka, Jakub Moskal, Jeremi Kościński, Iwona Krela-Kaźmierczak, Agnieszka Marta Lewandowska, Boushra Abou Hjeily, Paweł Gut, Karolina Hoffmann, Stefaan Van Gool, Nadia Sawicka-Gutaj, Marek Ruchała

Vol 74, No 3 (2023)

Review paper

Pubmed: 37695032
Endokrynol Pol 2023;74(3):221-233.
Clinical vignette2023, may 8

Ectopic parathyroid adenoma in a patient with multiple endocrine tumours

Inês Lemos Damásio, Inês Patrocínio Carvalho, Sara de Miranda Lemos Donato Bento, Valeriano Alberto Pais Horta Leite

Vol 74, No 3 (2023)

Clinical vignette

Pubmed: 37155305
Endokrynol Pol 2023;74(3):344-345.
Clinical vignette2023, may 8

Adverse outcome of T3-predominant maternal Grave’s disease during pregnancy in the mother and the offspring

Aleksandra Mikołajczak, Renata Bokiniec, Agnieszka Sienicka, Agata Pisula, Ewa Romejko-Wolniewicz

Vol 74, No 3 (2023)

Clinical vignette

Pubmed: 37155306
Endokrynol Pol 2023;74(3):340-341.
Original paper2023, may 8

MicroRNA-646 inhibits the proliferation of ovarian granulosa cells via insulin-like growth factor 1 (IGF-1) in polycystic ovarian syndrome (PCOS)

Jiali Lu, Feilan Xuan, Aixue Chen, Ruiying Jin, Weimei Zhou, Yongju Ye, Yuefang Ren

Vol 74, No 3 (2023)

Original paper

Pubmed: 37155307
Endokrynol Pol 2023;74(3):305-314.
Original paper2023, may 4

Leukocyte transcriptome of Cushing’s disease are associated with nerve impairment and psychiatric disorders

Kunyu He, Tao Zhou, Fuyu Wang, Fangye Li, Yanyang Zhang, Xinguang Yu

Vol 74, No 3 (2023)

Original paper

Pubmed: 37155308
Endokrynol Pol 2023;74(3):294-304.
Original paper2023, may 2

The association between complement C1q tumour necrosis factor-related protein-1 (CTRP-1) level and metabolic syndrome

Guirong Bai, Xiaomin Xie, Huili Liu, Dan Qiang, Yanting He, Li Zhang, Xiaojuan Zhang

Vol 74, No 3 (2023)

Original paper

Pubmed: 37155309
Endokrynol Pol 2023;74(3):271-276.
Original paper2023, may 2

The impact of subclinical hypothyroidism on growth and development in infants and young children aged 0 to 5 years

Xueqin Yan, Guomei Jiang, Chunhui Yang, Yuming Chen, Jie Zeng, Lianhong Huang, Xia Chen, Jialuo Liao

Vol 74, No 3 (2023)

Original paper

Pubmed: 37155310
Endokrynol Pol 2023;74(3):254-259.